The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Zonisamide is a medication used to treat the symptoms of epilepsy and Parkinson's disease.
The global Zonisamide market was valued at US$ 489 million in 2023 and is anticipated to reach US$ 718.8 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
North American market for Zonisamide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Zonisamide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Zonisamide include Concordia, Eisai, Zydus Pharmaceuticals, Sun Pharma, Wockhardt, Mylan, APOTEX, Teva and Glenmark, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Zonisamide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zonisamide.
Report Scope
The Zonisamide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Zonisamide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Zonisamide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Concordia
Eisai
Zydus Pharmaceuticals
Sun Pharma
Wockhardt
Mylan
APOTEX
Teva
Glenmark
Bluepharma
Invagen Pharmaceuticals
Intas Pharmaceuticals
Segment by Type
25mg
50mg
100mg
Segment by Application
Adult
Pediatric
Geriatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Zonisamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Zonisamide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Zonisamide is a medication used to treat the symptoms of epilepsy and Parkinson's disease.
The global Zonisamide market was valued at US$ 489 million in 2023 and is anticipated to reach US$ 718.8 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
North American market for Zonisamide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Zonisamide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Zonisamide include Concordia, Eisai, Zydus Pharmaceuticals, Sun Pharma, Wockhardt, Mylan, APOTEX, Teva and Glenmark, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Zonisamide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zonisamide.
Report Scope
The Zonisamide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Zonisamide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Zonisamide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Concordia
Eisai
Zydus Pharmaceuticals
Sun Pharma
Wockhardt
Mylan
APOTEX
Teva
Glenmark
Bluepharma
Invagen Pharmaceuticals
Intas Pharmaceuticals
Segment by Type
25mg
50mg
100mg
Segment by Application
Adult
Pediatric
Geriatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Zonisamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Zonisamide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Zonisamide Market Overview
1.1 Product Overview and Scope of Zonisamide
1.2 Zonisamide Segment by Type
1.2.1 Global Zonisamide Market Value Comparison by Type (2024-2030)
1.2.2 25mg
1.2.3 50mg
1.2.4 100mg
1.3 Zonisamide Segment by Application
1.3.1 Global Zonisamide Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Pediatric
1.3.4 Geriatric
1.4 Global Zonisamide Market Size Estimates and Forecasts
1.4.1 Global Zonisamide Revenue 2019-2030
1.4.2 Global Zonisamide Sales 2019-2030
1.4.3 Global Zonisamide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Zonisamide Market Competition by Manufacturers
2.1 Global Zonisamide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Zonisamide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Zonisamide Average Price by Manufacturers (2019-2024)
2.4 Global Zonisamide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Zonisamide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Zonisamide, Product Type & Application
2.7 Zonisamide Market Competitive Situation and Trends
2.7.1 Zonisamide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Zonisamide Players Market Share by Revenue
2.7.3 Global Zonisamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Zonisamide Retrospective Market Scenario by Region
3.1 Global Zonisamide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Zonisamide Global Zonisamide Sales by Region: 2019-2030
3.2.1 Global Zonisamide Sales by Region: 2019-2024
3.2.2 Global Zonisamide Sales by Region: 2025-2030
3.3 Global Zonisamide Global Zonisamide Revenue by Region: 2019-2030
3.3.1 Global Zonisamide Revenue by Region: 2019-2024
3.3.2 Global Zonisamide Revenue by Region: 2025-2030
3.4 North America Zonisamide Market Facts & Figures by Country
3.4.1 North America Zonisamide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Zonisamide Sales by Country (2019-2030)
3.4.3 North America Zonisamide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Zonisamide Market Facts & Figures by Country
3.5.1 Europe Zonisamide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Zonisamide Sales by Country (2019-2030)
3.5.3 Europe Zonisamide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Zonisamide Market Facts & Figures by Country
3.6.1 Asia Pacific Zonisamide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Zonisamide Sales by Country (2019-2030)
3.6.3 Asia Pacific Zonisamide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Zonisamide Market Facts & Figures by Country
3.7.1 Latin America Zonisamide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Zonisamide Sales by Country (2019-2030)
3.7.3 Latin America Zonisamide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Zonisamide Market Facts & Figures by Country
3.8.1 Middle East and Africa Zonisamide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Zonisamide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Zonisamide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Zonisamide Sales by Type (2019-2030)
4.1.1 Global Zonisamide Sales by Type (2019-2024)
4.1.2 Global Zonisamide Sales by Type (2025-2030)
4.1.3 Global Zonisamide Sales Market Share by Type (2019-2030)
4.2 Global Zonisamide Revenue by Type (2019-2030)
4.2.1 Global Zonisamide Revenue by Type (2019-2024)
4.2.2 Global Zonisamide Revenue by Type (2025-2030)
4.2.3 Global Zonisamide Revenue Market Share by Type (2019-2030)
4.3 Global Zonisamide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Zonisamide Sales by Application (2019-2030)
5.1.1 Global Zonisamide Sales by Application (2019-2024)
5.1.2 Global Zonisamide Sales by Application (2025-2030)
5.1.3 Global Zonisamide Sales Market Share by Application (2019-2030)
5.2 Global Zonisamide Revenue by Application (2019-2030)
5.2.1 Global Zonisamide Revenue by Application (2019-2024)
5.2.2 Global Zonisamide Revenue by Application (2025-2030)
5.2.3 Global Zonisamide Revenue Market Share by Application (2019-2030)
5.3 Global Zonisamide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Concordia
6.1.1 Concordia Corporation Information
6.1.2 Concordia Description and Business Overview
6.1.3 Concordia Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Concordia Zonisamide Product Portfolio
6.1.5 Concordia Recent Developments/Updates
6.2 Eisai
6.2.1 Eisai Corporation Information
6.2.2 Eisai Description and Business Overview
6.2.3 Eisai Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eisai Zonisamide Product Portfolio
6.2.5 Eisai Recent Developments/Updates
6.3 Zydus Pharmaceuticals
6.3.1 Zydus Pharmaceuticals Corporation Information
6.3.2 Zydus Pharmaceuticals Description and Business Overview
6.3.3 Zydus Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zydus Pharmaceuticals Zonisamide Product Portfolio
6.3.5 Zydus Pharmaceuticals Recent Developments/Updates
6.4 Sun Pharma
6.4.1 Sun Pharma Corporation Information
6.4.2 Sun Pharma Description and Business Overview
6.4.3 Sun Pharma Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharma Zonisamide Product Portfolio
6.4.5 Sun Pharma Recent Developments/Updates
6.5 Wockhardt
6.5.1 Wockhardt Corporation Information
6.5.2 Wockhardt Description and Business Overview
6.5.3 Wockhardt Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Wockhardt Zonisamide Product Portfolio
6.5.5 Wockhardt Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mylan Zonisamide Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 APOTEX
6.6.1 APOTEX Corporation Information
6.6.2 APOTEX Description and Business Overview
6.6.3 APOTEX Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 APOTEX Zonisamide Product Portfolio
6.7.5 APOTEX Recent Developments/Updates
6.8 Teva
6.8.1 Teva Corporation Information
6.8.2 Teva Description and Business Overview
6.8.3 Teva Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Teva Zonisamide Product Portfolio
6.8.5 Teva Recent Developments/Updates
6.9 Glenmark
6.9.1 Glenmark Corporation Information
6.9.2 Glenmark Description and Business Overview
6.9.3 Glenmark Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Glenmark Zonisamide Product Portfolio
6.9.5 Glenmark Recent Developments/Updates
6.10 Bluepharma
6.10.1 Bluepharma Corporation Information
6.10.2 Bluepharma Description and Business Overview
6.10.3 Bluepharma Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bluepharma Zonisamide Product Portfolio
6.10.5 Bluepharma Recent Developments/Updates
6.11 Invagen Pharmaceuticals
6.11.1 Invagen Pharmaceuticals Corporation Information
6.11.2 Invagen Pharmaceuticals Zonisamide Description and Business Overview
6.11.3 Invagen Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Invagen Pharmaceuticals Zonisamide Product Portfolio
6.11.5 Invagen Pharmaceuticals Recent Developments/Updates
6.12 Intas Pharmaceuticals
6.12.1 Intas Pharmaceuticals Corporation Information
6.12.2 Intas Pharmaceuticals Zonisamide Description and Business Overview
6.12.3 Intas Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Intas Pharmaceuticals Zonisamide Product Portfolio
6.12.5 Intas Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Zonisamide Industry Chain Analysis
7.2 Zonisamide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Zonisamide Production Mode & Process
7.4 Zonisamide Sales and Marketing
7.4.1 Zonisamide Sales Channels
7.4.2 Zonisamide Distributors
7.5 Zonisamide Customers
8 Zonisamide Market Dynamics
8.1 Zonisamide Industry Trends
8.2 Zonisamide Market Drivers
8.3 Zonisamide Market Challenges
8.4 Zonisamide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
